Results: 34
CORRIGENDUM.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1628, doi. 10.1002/ajh.26030
- Publication type:
- Article
Early combination treatment of immune thrombocytopenia: Is this the way?
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1452, doi. 10.1002/ajh.26024
- By:
- Publication type:
- Article
Risk‐adapted therapy in follicular lymphoma: Is it time to "FLEX"?
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1454, doi. 10.1002/ajh.26016
- By:
- Publication type:
- Article
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1599, doi. 10.1002/ajh.26008
- By:
- Publication type:
- Article
Severe infusion‐related reaction to crizanlizumab in an adolescent with sickle cell disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E338, doi. 10.1002/ajh.26002
- By:
- Publication type:
- Article
A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T‐cell acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E335, doi. 10.1002/ajh.25998
- By:
- Publication type:
- Article
BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E332, doi. 10.1002/ajh.25997
- By:
- Publication type:
- Article
A multicenter study evaluating the effectiveness and safety of single‐dose low molecular weight iron dextran vs single‐dose ferumoxytol for the treatment of iron deficiency.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1572, doi. 10.1002/ajh.25995
- By:
- Publication type:
- Article
The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1562, doi. 10.1002/ajh.25994
- By:
- Publication type:
- Article
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1553, doi. 10.1002/ajh.25992
- By:
- Publication type:
- Article
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E326, doi. 10.1002/ajh.25991
- By:
- Publication type:
- Article
A multicenter real‐life study on anticoagulant treatment with direct oral anticoagulants in patients with Ph‐negative myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E329, doi. 10.1002/ajh.25990
- By:
- Publication type:
- Article
High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1542, doi. 10.1002/ajh.25989
- By:
- Publication type:
- Article
The clinical and pathological features of plasma cell myeloma post solid organ transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1531, doi. 10.1002/ajh.25988
- By:
- Publication type:
- Article
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin‐American cohort of 212 patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E323, doi. 10.1002/ajh.25987
- By:
- Publication type:
- Article
Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI‐PIO) in chronic myeloid leukemia with deep molecular response.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E321, doi. 10.1002/ajh.25986
- By:
- Publication type:
- Article
Janus Family kinase (JAK) inhibitors in HLH and severe COVID‐19.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1448, doi. 10.1002/ajh.25985
- By:
- Publication type:
- Article
NK cell alloreactivity in acute myeloid leukemia in the post‐transplant cyclophosphamide era.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1590, doi. 10.1002/ajh.25983
- By:
- Publication type:
- Article
Thrombosis in COVID‐19.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1578, doi. 10.1002/ajh.25982
- By:
- Publication type:
- Article
"Double hit" anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1625, doi. 10.1002/ajh.25980
- By:
- Publication type:
- Article
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1522, doi. 10.1002/ajh.25979
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1511, doi. 10.1002/ajh.25978
- By:
- Publication type:
- Article
Compound heterozygous protein C variants undetectable by common laboratory testing causing purpura fulminans after the neonatal period.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1616, doi. 10.1002/ajh.25976
- By:
- Publication type:
- Article
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1473, doi. 10.1002/ajh.25961
- By:
- Publication type:
- Article
Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1495, doi. 10.1002/ajh.25972
- By:
- Publication type:
- Article
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)‐positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E319, doi. 10.1002/ajh.25967
- By:
- Publication type:
- Article
"ITP" is not always immune thrombocytopenia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1614, doi. 10.1002/ajh.25872
- By:
- Publication type:
- Article
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID‐19).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1479, doi. 10.1002/ajh.25962
- By:
- Publication type:
- Article
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1503, doi. 10.1002/ajh.25973
- By:
- Publication type:
- Article
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1457, doi. 10.1002/ajh.25958
- By:
- Publication type:
- Article
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1466, doi. 10.1002/ajh.25957
- By:
- Publication type:
- Article
Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1486, doi. 10.1002/ajh.25963
- By:
- Publication type:
- Article
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1622, doi. 10.1002/ajh.25806
- By:
- Publication type:
- Article
ISSUE INFORMATION – TABLE OF CONTENTS.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1445, doi. 10.1002/ajh.25541
- Publication type:
- Article